ESR1 and breast cancer: Triple-negative breast cancer (TNBC), accounting for approximately 15–20% of breast cancer cases, is characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor 2 (HER2) expression [1].